Braveheart Bio Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BRVE and other ETFs, options, and stocks.

About BRVE

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor.

CEO

Travis Murdoch, MD

CEOTravis Murdoch, MD

Employees

—

Employees—

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

Employees

—

Employees—

BRVE Key Statistics

Market cap

2.14B

Market cap2.14B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

$31.56

High today$31.56

Low today

$30.20

Low today$30.20

Open price

$30.20

Open price$30.20

Volume

1.17M

Volume1.17M

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

The current Braveheart Bio Inc(BRVE) stock price is $30.35, with a market capitalization of 2.14B.

On 2026-08-06, Braveheart Bio Inc(BRVE) stock traded between a low of $30.20 and a high of $31.56. Shares are currently priced at $30.35, which is +0.5% above the low and -3.8% below the high.

The Braveheart Bio Inc(BRVE)'s current trading volume is 1.17M.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.